Cargando…

A bisphosphonate for (19)F-magnetic resonance imaging

(19)F-magnetic resonance imaging (MRI) is a promising technique that may allow us to measure the concentration of exogenous fluorinated imaging probes quantitatively in vivo. Here, we describe the synthesis and characterisation of a novel geminal bisphosphonate ((19)F-BP) that contains chemically-eq...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenny, Gavin D., Shaw, Karen P., Sivachelvam, Saranja, White, Andrew J.P., Botnar, Rene M., T.M. de Rosales, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Sequoia Sa 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834630/
https://www.ncbi.nlm.nih.gov/pubmed/27110036
http://dx.doi.org/10.1016/j.jfluchem.2016.02.008
_version_ 1782427519240110080
author Kenny, Gavin D.
Shaw, Karen P.
Sivachelvam, Saranja
White, Andrew J.P.
Botnar, Rene M.
T.M. de Rosales, Rafael
author_facet Kenny, Gavin D.
Shaw, Karen P.
Sivachelvam, Saranja
White, Andrew J.P.
Botnar, Rene M.
T.M. de Rosales, Rafael
author_sort Kenny, Gavin D.
collection PubMed
description (19)F-magnetic resonance imaging (MRI) is a promising technique that may allow us to measure the concentration of exogenous fluorinated imaging probes quantitatively in vivo. Here, we describe the synthesis and characterisation of a novel geminal bisphosphonate ((19)F-BP) that contains chemically-equivalent fluorine atoms that show a single and narrow (19)F resonance and a bisphosphonate group that may be used for labelling inorganic materials based in calcium phosphates and metal oxides. The potential of (19)F-BP to provide contrast was analysed in vitro and in vivo using (19)F-MRI. In vitro studies demonstrated the potential of (19)F-BP as an MRI contrast agent in the millimolar concentration range with signal-to-noise ratios (SNR) comparable to previously reported fluorinated probes. The preliminary in vivo MRI study reported here allowed us to visualise the biodistribution of (19)F-BP, showing uptake in the liver and in the bladder/urinary system areas. However, bone uptake was not observed. In addition, (19)F-BP showed undesirable toxicity effects in mice that prevent further studies with this compound at the required concentrations for MRI contrast. This study highlights the importance of developing (19)F MRI probes with the highest signal intensity achievable.
format Online
Article
Text
id pubmed-4834630
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Sequoia Sa
record_format MEDLINE/PubMed
spelling pubmed-48346302016-04-20 A bisphosphonate for (19)F-magnetic resonance imaging Kenny, Gavin D. Shaw, Karen P. Sivachelvam, Saranja White, Andrew J.P. Botnar, Rene M. T.M. de Rosales, Rafael J Fluor Chem Article (19)F-magnetic resonance imaging (MRI) is a promising technique that may allow us to measure the concentration of exogenous fluorinated imaging probes quantitatively in vivo. Here, we describe the synthesis and characterisation of a novel geminal bisphosphonate ((19)F-BP) that contains chemically-equivalent fluorine atoms that show a single and narrow (19)F resonance and a bisphosphonate group that may be used for labelling inorganic materials based in calcium phosphates and metal oxides. The potential of (19)F-BP to provide contrast was analysed in vitro and in vivo using (19)F-MRI. In vitro studies demonstrated the potential of (19)F-BP as an MRI contrast agent in the millimolar concentration range with signal-to-noise ratios (SNR) comparable to previously reported fluorinated probes. The preliminary in vivo MRI study reported here allowed us to visualise the biodistribution of (19)F-BP, showing uptake in the liver and in the bladder/urinary system areas. However, bone uptake was not observed. In addition, (19)F-BP showed undesirable toxicity effects in mice that prevent further studies with this compound at the required concentrations for MRI contrast. This study highlights the importance of developing (19)F MRI probes with the highest signal intensity achievable. Elsevier Sequoia Sa 2016-04 /pmc/articles/PMC4834630/ /pubmed/27110036 http://dx.doi.org/10.1016/j.jfluchem.2016.02.008 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kenny, Gavin D.
Shaw, Karen P.
Sivachelvam, Saranja
White, Andrew J.P.
Botnar, Rene M.
T.M. de Rosales, Rafael
A bisphosphonate for (19)F-magnetic resonance imaging
title A bisphosphonate for (19)F-magnetic resonance imaging
title_full A bisphosphonate for (19)F-magnetic resonance imaging
title_fullStr A bisphosphonate for (19)F-magnetic resonance imaging
title_full_unstemmed A bisphosphonate for (19)F-magnetic resonance imaging
title_short A bisphosphonate for (19)F-magnetic resonance imaging
title_sort bisphosphonate for (19)f-magnetic resonance imaging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834630/
https://www.ncbi.nlm.nih.gov/pubmed/27110036
http://dx.doi.org/10.1016/j.jfluchem.2016.02.008
work_keys_str_mv AT kennygavind abisphosphonatefor19fmagneticresonanceimaging
AT shawkarenp abisphosphonatefor19fmagneticresonanceimaging
AT sivachelvamsaranja abisphosphonatefor19fmagneticresonanceimaging
AT whiteandrewjp abisphosphonatefor19fmagneticresonanceimaging
AT botnarrenem abisphosphonatefor19fmagneticresonanceimaging
AT tmderosalesrafael abisphosphonatefor19fmagneticresonanceimaging
AT kennygavind bisphosphonatefor19fmagneticresonanceimaging
AT shawkarenp bisphosphonatefor19fmagneticresonanceimaging
AT sivachelvamsaranja bisphosphonatefor19fmagneticresonanceimaging
AT whiteandrewjp bisphosphonatefor19fmagneticresonanceimaging
AT botnarrenem bisphosphonatefor19fmagneticresonanceimaging
AT tmderosalesrafael bisphosphonatefor19fmagneticresonanceimaging